As advertisers pay more for an ever-scarcer supply of ratings points, pharma’s ironclad devotion to TV could finally be in ...

AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, today announced the appointment of Alan Colowick, M.D ...

Growing demand for tryptamine APIs stems from their anti-cancer potential, pharmaceutical uses, and role as a neurotransmitter modulator i ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

NEW YORK CITY, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to ...

For the 10th anniversary of America’s Best Large and Midsize Employers, Forbes is recognizing 77 Best Employer ...

Digital Biomanufacturing Market Forecasts to 2035: 140+ Platforms, based on PAT, DAS, MES, Digital Twins and other Technologies, are being Offered for Digitalization of the Biologic Production Process ...

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...

SROA Capital has generously stepped up as the Diamond Sponsor for PBA's 33rd Annual Luncheon, where two local women of distinction, Penny G. Murphy and Amanda Schumacher, will share the spotlight on ...